Emerald Clinics Ltd (EMD)
20mins delayed
Movement
1 Year Return
Emerald Clinics Ltd Chart
| Share price | |
| Last | |
| Change | |
| Volume | |
| Turnover | |
| Market Cap | $9.57 million |
| Today's Movement | |
| Prev. Close | |
| Open | |
| Day Range | - |
| VWAP | |
| Historical Stats | |
| 52w Range | - |
| 4w Avg Volume | |
| 4w Avg Turnover | |
| (delayed) | |
EMD Statistics
17 September
1,867 / 2,226
ASX Size Rank
1yr Return
vs Sector (1yr)
-58.47%
vs ASX 200 (1yr)
-28.74%
$9.57 million
Market Cap
Share Issue
111.31 million
All Ords (%)
N/A
Short Sold
0%
Current Fundamentals
17 September
N/A
PE Ratio
EPS ($)
-
Earnings Yield
-
NTA ($)
-
N/A
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
Emerald Clinics Limited (EMD) operates a network of specialist medical clinics (Clinics) and uses purpose-built software and technology to gather high quality clinical data from informed and consenting patients. Emerald is a clinical services and healthcare technology company focused on the provision of care for patients clinically determined to have exhausted conventional therapies and who may be suitable for cannabinoid-based medicines.
Upcoming Calendar
| 26 Feb 2021 | Report (Interim) |
| 30 Aug 2021 | Report (Prelim) |
Dividend History
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| No dividends paid in the last 5 years | ||||
See Upcoming Dividends for all ASX companies.
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Announcements provided by
Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
EMD is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.
Directors & Management
| Name | Title | Since | Bio |
|---|---|---|---|
| Mr Matthew (Matt) Callahan | Non-Executive Director | Mar 2018 |
|
| Dr Stewart James Washer | Executive Chairman, Executive Director | Mar 2018 |
|
| Sir John Tooke | Non-Executive Director | Feb 2020 |
|
| Dr Michael Winlo | Managing Director | Nov 2019 |
|
| Dr Alistair Vickery | Executive Director | Nov 2018 |
|
| Su-Mei Sain | Chief Financial Officer | N/A | |
| Adam James | Chief Operating Officer | N/A | |
| Simon Lee Robertson | Company Secretary | N/A |
Director Transactions
EMD directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
| Date | Director | Type | Amount | Price | Value | Notes |
|---|---|---|---|---|---|---|
| 16/03/20 | Stewart Washer | Buy | +100,000 | $0.061 | $6,110 | On-market trade. |
| 10/03/20 | Stewart Washer | Buy | +58,500 | $0.090 | $5,290 | On-market trade. |
| 09/03/20 | Stewart Washer | Buy | +120,500 | $0.089 | $10,667 | On-market trade. |
| 06/03/20 | Stewart Washer | Buy | +271,499 | $0.089 | $24,182 | On-market trade. |
Shareholder Distribution
Shareholder Distribution data is unavailable.
Top 20 Shareholders
No data available. Most companies release Top 20 Shareholders data in their Annual Report but it's not compulsory.
EMD Share Price History
| Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
EMD Historical Data
Download up to 20 years of share price history.
| Year | Closing Price (30 June) | Last Trade |
|---|---|---|
| 2020 | $0.048 | 30 June |
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: Operates a network of specialist medical clinics and uses purpose built software and technology to gather clinical data from consenting patients. The anonymised data is commercialised as clinical evidence.
Incorporated: --
Level 1, 50 Angove St
North Perth WA 6006
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.